ClinicalTrials.gov
public full text
Public Domain
BBPA PET/CT in Patients With Malignant Tumors
This study is an open-labeled phase II diagnostic clinical trial to explore the safety and clinical value of BBPA-PET/CT in suspected malignant tumor patients. The investigation regarding the clinical value of BBPA concerning the metabolic characteristics of BBPA in suspected malignant tumors. Quantitative features will be extracted to analysis the PET images. For patient who took surgery after multiple examination, histopathology, molecular pathology and LAT-1 immunohistochemistry will also be obtained.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 68Ga-PSMA PET in the Renal Cell Carcinoma#897921
- Cardiac FDG PET Viability Registry#802028
- 68Ga-FAPI PET/CT in Patients With Various Types of Cancer#841942
- Value of ctDNA in the Treatment of Multiple Primary Cancers#840843
- Yeni̇ tanı di̇ffüz büyük b hücreli̇ lenfoma hastalarında kli̇ni̇k prognosti̇k faktörler i̇le FDG PET/BT'de tüm vücut metaboli̇k tümör volümünün hastalık sağkalımı üzeri̇ne etki̇si̇#203165
Record · ID 910360
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive